Related Experiment Video
Updated: Jun 29, 2025

11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
5.6K
Using artificial intelligence to predict choledocholithiasis: can machine learning models abate the use of MRCP in
Joshua Blum1, Sam Hunn1, Jules Smith1
1Department of General Surgery, Royal Hobart Hospital, Hobart, Tasmania, Australia.
ANZ Journal of Surgery
|March 25, 2024
Summary
Machine learning models accurately predict choledocholithiasis risk, potentially reducing the need for expensive magnetic resonance cholangiopancreatography (MRCP) and enabling faster interventions for patients.
Area of Science:
- Hepatobiliary Medicine
- Medical Informatics
- Artificial Intelligence in Healthcare
Background:
- Prompt diagnosis of choledocholithiasis is critical for patient outcomes and resource management.
- Magnetic resonance cholangiopancreatography (MRCP) is a common but costly diagnostic tool that can delay treatment.
- Developing predictive models can optimize patient care pathways for suspected choledochocholithiasis.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting choledocholithiasis risk.
- To compare ML model performance against existing clinical guidelines (ASGE).
- To identify clinical and imaging factors that predict choledocholithiasis.
Main Methods:
- Retrospective analysis of 222 inpatients with suspected choledocholithiasis.
- Utilized logistic regression, XGBoost, random forest, and K-nearest neighbours ML techniques.
- Developed an ensemble model from the top three performing ML models.
Main Results:
- Machine learning models demonstrated high accuracy (up to 0.81 AUROC) in predicting choledocholithiasis.
- All developed models outperformed the ASGE risk stratification guidelines.
- Key predictive factors included common bile duct diameter, lipase levels, cholelithiasis on imaging, and liver function tests.
Conclusions:
- ML models offer a viable tool for accurately assessing choledocholithiasis risk.
- These models may help identify patients suitable for direct intervention, bypassing MRCP.
- Further validation with prospective data is required to confirm clinical utility and refine accuracy.

